Review on IFN drugs
02/24/2022Congratulations to Niklas Hauptstein & team for their review ”Bioconjugation strategies and clinical implications of Interferon-bioconjugates“, published in the European Journal of Pharmaceutics and Biopharmaceutics. The article reviews available IFN drugs, their field and route of application, while also outlining available and future strategies for bioconjugation to further optimize pharmaceutical and clinical performances of all three available IFN classes.
https://www.sciencedirect.com/science/article/abs/pii/S0939641122000273
Reprinted with permission from Niklas Hauptstein, Lorenz Meinel, Tessa Lühmann,
Bioconjugation strategies and clinical implications of Interferon-bioconjugates,
European Journal of Pharmaceutics and Biopharmaceutics,
Copyright 2022, with permission from Elsevier/European Journal of Pharmaceutics and Biopharmaceutics
Back